| Detection of circulating tumor DNA in early-and late-stage human malignancies C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... Science translational medicine 6 (224), 224ra24-224ra24, 2014 | 4146 | 2014 |
| Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune EscapeLAG-3 and PD-1 Synergistically Prevent Antitumor Immunity SR Woo, ME Turnis, MV Goldberg, J Bankoti, M Selby, CJ Nirschl, ... Cancer research 72 (4), 917-927, 2012 | 1512 | 2012 |
| TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, ... Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013 | 1400 | 2013 |
| Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology JL Mohler, ES Antonarakis, AJ Armstrong, AV D’Amico, BJ Davis, T Dorff, ... Journal of the National Comprehensive Cancer Network 17 (5), 479-505, 2019 | 1017 | 2019 |
| In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas D Bell, P Chomarat, D Broyles, G Netto, GM Harb, S Lebecque, ... The Journal of experimental medicine 190 (10), 1417-1426, 1999 | 663 | 1999 |
| Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements MC Haffner, MJ Aryee, A Toubaji, DM Esopi, R Albadine, B Gurel, ... Nature genetics 42 (8), 668-675, 2010 | 636 | 2010 |
| LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems JF Grosso, CC Kelleher, TJ Harris, CH Maris, EL Hipkiss, A De Marzo, ... The Journal of clinical investigation 117 (11), 3383-3392, 2007 | 578 | 2007 |
| Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ... The American journal of pathology 179 (4), 1608-1615, 2011 | 501 | 2011 |
| Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers MC Haffner, A Chaux, AK Meeker, DM Esopi, J Gerber, LG Pellakuru, ... Oncotarget 2 (8), 627, 2011 | 460 | 2011 |
| PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients TL Lotan, B Gurel, S Sutcliffe, D Esopi, W Liu, J Xu, JL Hicks, BH Park, ... Clinical cancer research 17 (20), 6563-6573, 2011 | 372 | 2011 |
| A distinctive subset of PEComas harbors TFE3 gene fusions P Argani, S Aulmann, PB Illei, GJ Netto, J Ro, H Cho, S Dogan, M Ladanyi, ... The American journal of surgical pathology 34 (10), 1395-1406, 2010 | 366 | 2010 |
| Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity J Nemunaitis, C Cunningham, A Buchanan, A Blackburn, G Edelman, ... Gene therapy 8 (10), 746-759, 2001 | 353 | 2001 |
| Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. AS Sarkis, DF Bajorin, VE Reuter, HW Herr, G Netto, ZF Zhang, ... Journal of clinical oncology 13 (6), 1384-1390, 1995 | 319 | 1995 |
| Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma HL Tan, A Sood, HA Rahimi, W Wang, N Gupta, J Hicks, S Mosier, ... Clinical cancer research 20 (4), 890-903, 2014 | 316 | 2014 |
| Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. HI Scher, A Sarkis, V Reuter, D Cohen, G Netto, D Petrylak, P Lianes, ... Clinical cancer research: an official journal of the American Association …, 1995 | 302 | 1995 |
| Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer … AW Tong, J Nemunaitis, D Su, Y Zhang, C Cunningham, N Senzer, ... Molecular therapy 11 (1), 160-172, 2005 | 266 | 2005 |
| UALCAN: An update to the integrated cancer data analysis platform DS Chandrashekar, SK Karthikeyan, PK Korla, H Patel, AR Shovon, ... Neoplasia 25, 18-27, 2022 | 265 | 2022 |
| TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg, T Bivalacqua, ... Cancer research 73 (24), 7162-7167, 2013 | 255 | 2013 |
| Long interspersed element-1 protein expression is a hallmark of many human cancers N Rodić, R Sharma, R Sharma, J Zampella, L Dai, MS Taylor, RH Hruban, ... The American journal of pathology 184 (5), 1280-1286, 2014 | 250 | 2014 |
| Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ... European urology 69 (1), 157-165, 2016 | 245 | 2016 |
Alcides Chaux, M.D.Office of Scientific Research, Norte University, AsunciónVerified email at uninorte.edu.py
